Cure SMA Featured in the NFL’s My Cause My Cleats

Cure SMA is thrilled to have recently been featured in the National Football League’s (NFL) My Cause My Cleats campaign. Through this fantastic initiative, players select a charitable organization and cause of choice, in order to increase awareness by wearing cleats decorated in honor of that cause. For Rachaad White, Tampa Bay Buccaneers running back, […]

Cure SMA Featured in the NFL’s My Cause My Cleats Read More »

Administration Officials & Members of Congress Highlight SMA Community Advocacy at 12th Annual Hope on the Hill Washington, D.C. Event 

Two high-ranking Administration officials and several Members of Congress from key congressional committees participated in Cure SMA’s November 29th Hope on the Hill dinner and reception, an annual Washington, D.C. event that raises awareness about spinal muscular atrophy (SMA) with key government officials. The 2023 event highlighted key SMA community advocacy priorities, including accessible air

Administration Officials & Members of Congress Highlight SMA Community Advocacy at 12th Annual Hope on the Hill Washington, D.C. Event  Read More »

Sweet Success: Baking a Difference Returns for a Second Year

Breaking and Baking News!   Get ready to dust off those aprons and preheat those ovens because Baking a Difference is back and better than ever for its second year! Created by kids, for kids, with hearts as sweet as the treats they bake, this heartwarming campaign is all set to spread joy and make

Sweet Success: Baking a Difference Returns for a Second Year Read More »

Genentech Shares 1-Year Primary Analysis from RAINBOWFISH

Last week, Genentech, a member of the Roche Group,  presented positive results from the primary analysis of the ongoing RAINBOWFISH study assessing the efficacy and safety of Evrysdi® (risdiplam) in babies with pre-symptomatic SMA, aged from birth to 6 weeks. These data were presented at the 28th World Muscle Society (WMS) Congress. Read more about

Genentech Shares 1-Year Primary Analysis from RAINBOWFISH Read More »

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development

An important part of Cure SMA’s core mission is to carry out and support research that will improve the quality of life for all people with SMA. We recently published a new research article, “Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.” This article appeared in the July 12, 2023 issue of the peer-reviewed

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development Read More »

Scroll to Top